首页|University of Cambridge Reports Findings in Personalized Medicine (Decoding Glio blastoma Heterogeneity: Neuroimaging Meets Machine Learning)
University of Cambridge Reports Findings in Personalized Medicine (Decoding Glio blastoma Heterogeneity: Neuroimaging Meets Machine Learning)
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
By a News Reporter-Staff News Editor at Robotics & Machine Learning DailyNews Daily News – New research on Drugs and Therapies - Personalized Medicine is the subject of a report.According to news originating from Cambridge, United Kingdom, by NewsRx correspondents, researchstated, “Rece nt advancements in neuroimaging and machine learning have significantly improved our abilityto diagnose and categorize isocitrate dehydrogenase (IDH)-wildtype glioblastoma, a disease characterizedby notable tumoral heterogeneity, which is crucial for effective treatment. Neuroimaging techniques, suchas diffusion ten sor imaging and magnetic resonance radiomics, provide noninvasive insights into tumorinfiltration patterns and metabolic profiles, aiding in accurate diagnosis and prognostication.”
CambridgeUnited KingdomEuropeCance rCyborgsDrugs and TherapiesEmerging TechnologiesGlioblastomasHealth an d MedicineMachine LearningNeuroimagingOncologyPersonalized MedicinePer sonalized Therapy
NETL
NSTL
